12 recruiting, 10 completed, 10 not yet recruiting, 6 unknown. 14 Phase 1, 11 Phase 2, 3 Early Phase 1, 1 Phase 3, 1 Phase 4.
Follow Autoimmune Hemolytic Anemia: new trials by email Literature Review of Autoimmune Hemolytic Anemia trials Research Report on Autoimmune Hemolytic Anemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia YTS109 cell - Autoimmune Hemolytic Anemia | Phase 1 | Not yet recruiting | China Immunotech (Beijing) Biotechnology Co., Ltd. | 13 | 2026-11-18 | 2026-10-22 |
| Phase 1 Study of F182112 in Relapsed/Refractory Autoimmune Hemolytic Anemia F182112 single-agent - Autoimmune Hemolytic Anemia | Phase 1 | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 12 | 2026-10-10 | 2026-09-11 |
| Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE) BMS-986353, Fludarabine Phosphate, Cyclophosphamide - Chronic Immune Thrombocytopenia, Autoimmune Hemolytic Anemia | Phase 2 | Not yet recruiting | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 52 | 2026-08-31 | 2026-07-09 |
| IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia IASO206 injection - Autoimmune Hemolytic Anemia, Relapsed/Refractory | Phase 1 | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 18 | 2026-06-15 | 2026-05-13 |
| UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases CART Infusion - Autoimmune Hemolytic Anemia, Primary Immune Thrombocytopenic Purpura | Early Phase 1 | Recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 27 | 2026-02-03 | 2026-03-02 |
| A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia YTS109 cell - Autoimmune Hemolytic Anemia | Phase 1 | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 13 | 2025-12-25 | 2025-12-17 |
| A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia CM336 Injection - Autoimmune Cytopenia, Immune Thrombocytopenia (ITP) | Phase 1 / Phase 2 | Recruiting | Keymed Biosciences Co.Ltd | 158 | 2025-11-18 | 2025-12-17 |
| Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS Aplastic Anemia, Myelodysplastic Syndromes | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 323 | 2025-10-11 | 2026-09-18 | |
| A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia enatumab - Autoimmune Hemolytic Anemia | Phase 2 | Not yet recruiting | Bing Han | 3 | 2025-09-18 | 2025-09-24 |
| A Single-arm Phase 2 Prospective Clinical Study of Linprixel in the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia Parsaclisib - Autoimmune Hemolytic Anemia | Not yet recruiting | Peking Union Medical College Hospital | 22 | 2025-09-01 | 2025-09-02 | |
| UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases universal allogeneic anti-CD19/BCMA CAR T-cells - Systemic Lupus Erythematosus, Autoimmune Hemolytic Anemia | Phase 1 | Not yet recruiting | Changzhou No.2 People's Hospital | 18 | 2025-05-01 | 2025-05-18 |
| Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia Brain function and psychological assessment - CAR T-cell Therapy, Autoimmune Hemolytic Anemia | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 20 | 2025-02-25 | 2025-08-05 | |
| A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia YTS109 - Autoimmune Hemolytic Anemia, Anti-CD19 STAR T-cell Therapy | Phase 1 | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 7 | 2025-01-16 | 2025-01-13 |
| A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia YTS109 cell - Autoimmune Hemolytic Anemia | Phase 1 | Completed | China Immunotech (Beijing) Biotechnology Co., Ltd. | 7 | 2025-01-15 | 2026-03-02 |
| CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy. universal allogeneic anti-CD19/BCMA CAR T-cells - Autoimmune Hemolytic Anemia, CD19/BCMA CAR T-cells | Phase 1 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 15 | 2024-12-05 | 2024-12-13 |
| Safety Study of CC312 in Autoimmune Disease Patients CC312 - Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathy (IIM) | Early Phase 1 | Recruiting | CytoCares Inc | 18 | 2024-11-08 | 2025-09-17 |
| CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. CNCT19 CAR-T cell therapy - Autoimmune Hemolytic Anemia, Autologous CD19 CAR-T | Phase 1 | Active not recruiting | Institute of Hematology & Blood Diseases Hospital, China | 6 | 2024-02-04 | 2025-05-16 |
| CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy ThisCART19A - Autoimmune Hemolytic Anemia, CD19 CAR-T Cell Infusion | Phase 1 | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 13 | 2024-01-20 | 2024-03-22 |
| Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL Ibrutinib 420 mg - Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia | Phase 2 | Recruiting | Gruppo Italiano Malattie EMatologiche dell'Adulto | 45 | 2023-11-24 | 2023-12-01 |
| Presence of Circulating Cluster of Differentiation 4 Positive 28 Null T Helper Lymphocytes(CD4+CD28-) in Patients With Autoimmune Hemolytic Anemia. Autoimmune Hemolytic Anemia | Unknown | Assiut University | 46 | 2023-01-30 | 2023-02-02 |
Showing 20 of 43. Sign in to see all of them.
Anemia, Hemolytic, Autoimmune (43) · Purpura, Thrombocytopenic, Idiopathic (9) · Evans Syndrome (8) · Lupus Erythematosus, Systemic (3) · Myelodysplastic Syndromes (3) · Recurrence (3) · Anemia (2) · Anemia, Aplastic (2) · Hemolysis (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Myositis (2) · Scleroderma, Systemic (2) · Thrombocytopenia (2) · Amyloidosis (1) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)
Anemia, Hemolytic (43) · Hemic and Lymphatic Diseases (43) · Immune System Diseases (43) · Autoimmune Diseases (42) · Hematologic Diseases (42) · Anemia (41) · Pathologic Processes (15) · Pathological Conditions, Signs and Symptoms (15) · Blood Platelet Disorders (10) · Cytopenia (10) · Blood Coagulation Disorders (9) · Hemorrhage (9) · Hemorrhagic Disorders (9) · Purpura (9) · Purpura, Thrombocytopenic (9)
Blood Specimen Collection (3) · Rituximab (3) · parsaclisib (2) · Bendamustine Hydrochloride (1) · Bortezomib (1) · Crisis Intervention (1) · Cyclophosphamide (1) · Data Collection (1) · Erythropoietin (1) · Fecal Microbiota Transplantation (1) · Granulocyte Colony-Stimulating Factor (1) · Injections (1) · KZR-616 (1) · Mycophenolic Acid (1) · Tacrolimus (1)
Institute of Hematology & Blood Diseases Hospital, China (9) · Assiut University (4) · University Hospital, Bordeaux (4) · Centre Hospitalier Universitaire Dijon (3) · Peking Union Medical College Hospital (3) · China Immunotech (Beijing) Biotechnology Co., Ltd. (2) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (2) · Bing Han (1) · Changzhou No.2 People's Hospital (1) · City of Hope Medical Center (1) · CytoCares Inc (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · Gruppo Italiano Malattie EMatologiche dell'Adulto (1) · Helse Fonna (1) · Incyte Corporation (1)
China (17) · France (8) · United States (5) · Italy (4) · Austria (2) · Denmark (2) · Egypt (2) · Australia (1) · Finland (1) · Germany (1) · Netherlands (1) · Norway (1) · Poland (1) · Russia (1) · United Kingdom (1)
Jun Shi (2) · Alexey Danilov (1) · Bing Han (1) · Bing Hang, PhD (1) · Essam Abdel Monem El-beih, professor (1) · Geir E Tjonnfjord, MD, PhD (1) · He Huang, PhD (1) · Henrik Birgens, MD, PhD (1) · Kathleen Butler, MD (1) · M. De Haas, Prof. MD PhD (1) · Markku Oksman, MD (1)
PMID 16041665, PMID 18644324, PMID 19055865, PMID 19105232, PMID 19819109, PMID 24034070, PMID 25271314, PMID 26696797, PMID 26696800, PMID 28533306, PMID 30408135, PMID 32611669, PMID 37534543, PMID 38013593, PMID 38029356, PMID 38227934, PMID 39435908, PMID 39874521, PMID 41534043
2014 (1), 2017 (1), P30CA033572 (1)